thought break-up fee deal spread
merger agreement provid detail break-up fee merger
disallow regul pay esrx bln termin fee
addit esrx termin merger agreement due
reason relat regulatori approv parti
termin agreement would pay parti termin fee
bln current merger agreement run decemb
subject six-month extens either esrx june
termin fee percentag deal price seem reason
break-up fee bln repres bln transact equiti valu
compar bln bln deal case cvs-aet
bln bln deal case antm-ci bln
bln deal case aet-hum propos transact
quick thought deal spread friday close share price ci
esrx impli purchas price esrx per share
friday close price esrx share trade deal
spread seem reason in-lin expect
comparison aet-cv share trade deal spread
adjust pt new blend approach put probabl ci-
esrx deal get approv deal-approv scenario
use blend pt multipl pro-forma ex-antm contract
ep estimate deal-reject scenario use
pt multipl vs previous ep estimate adjust
lack share buy-back impact break-up fee
all-in probabl weight pt vs previous still
attract upsid risk rate tp ci relat
continu enrol pressur busi potenti advers
rule litig break-up fee owe ci
oper disrupt result propos ci-esrx transact
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
headquart bloomfield ct global health servic
health global supplement benefit group disabl
life
price rate outperform target price analyst rice
profit tax
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
total debt capit
blue sky valuat assum ci-esrx deal approv
pro-forma compani report major disrupt among
client well manag settlement litig
scenario believ pro-forma compani trade
grey sky valuat assum ci-esrx deal reject
stand-alon compani see continu disrupt
medicar advantag busi scenario see ci
share trade ex-shar buy-back ep estim
 close
announc ci-esrx switch pt methodolog approach
probabl weight blend pt approach put probabl ci-
esrx deal get approv similar probabl put aet-cv
deal-approv scenario use blend pt multipl pro-
forma ex-antm contract ep estim believ pro-forma
compani warrant given uncertainti around outcom esrx-antm litig
retent esrx client compani acquir
deal-reject scenario use pt multipl vs previous
ep estim adjust lack share buy-back impact
break-up fee prior primarili reflect compani strong financi
all-in probabl weight pt vs previous still attract
impact break-up fee
pt adjust break-up fee
approv scenario publish merger model reject scenario adjust share buy-back
compani mention price
 rice certifi view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend view express report
price rate histori aetna inc aet
signifi initi assumpt coverag
effect juli nc denot termin coverag
price rate histori inc antm
signifi initi assumpt coverag
effect juli nc denot termin coverag
charl martineau pm univers toronto price rate histori
signifi initi assumpt coverag
price rate histori cigna corpor ci
signifi initi assumpt coverag
effect juli nc denot termin coverag
price rate histori express script esrx oq
signifi initi assumpt coverag
analyst respons prepar research report receiv compens base upon variou factor includ credit suiss
total revenu portion gener credit suiss invest bank activ
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attract neutral less attract
underperform least attract invest opportun octob canadian well european rate base stock total
return rel analyst coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun latin american asia stock exclud japan
australia rate base stock total return rel averag total return relev countri region benchmark india bse sensex
prior octob canadian rate base stock absolut total return potenti current share price rel
attract stock total return potenti within analyst coverag univers australian new zealand stock expect total return
calcul includ roll dividend yield outperform rate assign greater equal under-perform
less equal neutral may assign overlap rate rang allow analyst assign rate
put context associ risk prior may rang outperform under-perform rate overlap neutral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
rate nr credit suiss equiti research invest rate view stock secur relat
compani time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest
view equiti secur compani relat product
volatil indic stock defin volatil stock price move month least past
month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or
valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform close
